RNA decay: A novel therapeutic target in bacteria

Wiley Interdisciplinary Reviews: RNA

Volumn 3, Issue 3, 2012, Pages 443-454

  Eidem, Tess M ^a   Roux, Christelle M ^b   Dunman, Paul M ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; MESSENGER RNA; RIBONUCLEASE; RIBONUCLEASE INHIBITOR; RNA;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; CELL DAMAGE; DISEASE SEVERITY; DRUG RESEARCH; DRUG TARGETING; HUMAN; INCIDENCE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; RNA DECAY; RNA DEGRADATION; SCREENING TEST;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; RIBONUCLEASES; RNA STABILITY; RNA, MESSENGER;

EID: 84867597834     PISSN: 17577004     EISSN: 17577012     Source Type: Journal    
DOI: 10.1002/wrna.1110     Document Type: Article

References (92)

1. Morens DM, Folkers GK, Fauci AS. The challenge of emerging and re-emerging infectious diseases. Nature 2004, 430:242-249.
2. Spellberg B, Blaser M, Guidos RJ, Boucher HW, Bradley JS, Eisenstein BI, Gerding D, Lynfield R, Reller LB, Rex J, et al. Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis 2011, 52 (Suppl 5):S397-S428.
3. Fischbach MA, Walsh CT. Antibiotics for emerging pathogens. Science 2009, 325:1089-1093.
4. Nathan C. Antibiotics at the crossroads. Nature 2004, 431:899-902.
5. Kushner SR. mRNA decay in prokaryotes and eukaryotes: different approaches to a similar problem. IUBMB Life 2004, 56:585-594.
6. Tomecki R, Dziembowski A. Novel endoribonucleases as central players in various pathways of eukaryotic RNA metabolism. RNA 2010, 16:1692-1724.
7. Condon C. Maturation and degradation of RNA in bacteria. Curr Opin Microbiol 2007, 10:271-278.
8. Anderson KL, Dunman PM. Messenger RNA turnover processes in Escherichia coli, Bacillus subtilis, and emerging studies in Staphylococcus aureus. Int J Microbiol 2009. Article ID 525491.
9. Liu Q, Greimann JC, Lima CD. Reconstitution, activities, and structure of the eukaryotic RNA exosome. Cell 2006, 127:1223-1237.
10. Garneau NL, Wilusz J, Wilusz CJ. The highways and byways of mRNA decay. Nat Rev Mol Cell Biol 2007, 8:113-126.
11. Morrison JM, Dunman PM. The modulation of Staphylococcus aureus mRNA turnover. Future Microbiol 2011, 6:1141-1150.
12. Carpousis AJ. The Escherichia coli RNA degradosome: structure, function and relationship in other ribonucleolytic multienzyme complexes. Biochem Soc Trans 2002, 30:150-155.
13. Deana A, Celesnik H, Belasco JG. The bacterial enzyme RppH triggers messenger RNA degradation by 5' pyrophosphate removal. Nature 2008, 451:355-358.
14. Carpousis AJ, Van Houwe G, Ehretsmann C, Krisch HM. Copurification of E. coli RNAase E and PNPase: evidence for a specific association between two enzymes important in RNA processing and degradation. Cell 1994, 76:889-900.
15. Gupta RS, Kasai T, Schlessinger D. Purification and some novel properties of Escherichia coli RNase II. J Biol Chem 1977, 252:8945-8949.
16. Cheng ZF, Deutscher MP. An important role for RNase R in mRNA decay. Mol Cell 2005, 17:313-318.
17. Ito R, Ohnishi Y. The roles of RNA polymerase and RNase I in stable RNA degradation in Escherichia coli carrying the srnB+ gene. Biochim Biophys Acta 1983, 739:27-34.
18. Umitsuki G, Wachi M, Takada A, Hikichi T, Nagai K. Involvement of RNase G in in vivo mRNA metabolism in Escherichia coli. Genes Cells 2001, 6:403-410.
19. Drider D, Condon C. The continuing story of endoribonuclease III. J Mol Microbiol Biotechnol 2004, 8:195-200.
20. Zhang X, Zhu L, Deutscher MP. Oligoribonuclease is encoded by a highly conserved gene in the 3'-5' exonuclease superfamily. J Bacteriol 1998, 180:2779-2781.
21. Altman S, Wesolowski D, Guerrier-Takada C, Li Y. RNase P cleaves transient structures in some riboswitches. Proc Natl Acad Sci U S A 2005, 102:11284-11289.
22. Li Y, Altman S. A specific endoribonuclease, RNase P, affects gene expression of polycistronic operon mRNAs. Proc Natl Acad Sci U S A 2003, 100:13213-13218.
23. Alifano P, Rivellini F, Piscitelli C, Arraiano CM, Bruni CB, Carlomagno MS. Ribonuclease E provides substrates for ribonuclease P-dependent processing of a polycistronic mRNA. Genes Dev 1994, 8:3021-3031.
24. Ghosh S, Deutscher MP. Oligoribonuclease is an essential component of the mRNA decay pathway. Proc Natl Acad Sci U S A 1999, 96:4372-4377.
25. Ghora BK, Apirion D. Structural analysis and in vitro processing to p5 rRNA of a 9S RNA molecule isolated from an rne mutant of E. coli. Cell 1978, 15:1055-1066.
26. Ow MC, Kushner SR. Initiation of tRNA maturation by RNase E is essential for cell viability in E. coli. Genes Dev 2002, 16:1102-1115.
27. Commichau FM, Rothe FM, Herzberg C, Wagner E, Hellwig D, Lehnik-Habrink M, Hammer E, Volker U, Stulke J. Novel activities of glycolytic enzymes in Bacillus subtilis: interactions with essential proteins involved in mRNA processing. Mol Cell Proteomics 2009, 8:1350-1360.
28. Roux CM, Demuth JP, Dunman PM. Characterization of components of the Staphylococcus aureus messenger RNA degradosome holoenzyme-like complex. J Bacteriol 2011, 193:5520-5526.
29. Mathy N, Hebert A, Mervelet P, Benard L, Dorleans A, Li de la Sierra-Gallay I, Noirot P, Putzer H, Condon C Bacillus subtilis ribonucleases J1 and J2 form a complex with altered enzyme behaviour. Mol Microbiol 2010, 75:489-498.
30. Richards J, Liu Q, Pellegrini O, Celesnik H, Yao S, Bechhofer DH, Condon C, Belasco JG. An RNA pyrophosphohydrolase triggers 5'-exonucleolytic degradation of mRNA in Bacillus subtilis. Mol Cell 2011, 43:940-949.
31. Shahbabian K, Jamalli A, Zig L, Putzer H. RNase Y, a novel endoribonuclease, initiates riboswitch turnover in Bacillus subtilis. EMBO J 2009, 28:3523-3533.
32. Lehnik-Habrink M, Newman J, Rothe FM, Solovyova AS, Rodrigues C, Herzberg C, Commichau FM, Lewis RJ, Stulke J. RNase Y in Bacillus subtilis: a natively disordered protein that is the functional equivalent of RNase E from Escherichia coli. J Bacteriol 2011, 193:5431-5441.
33. Condon C, Bechhofer DH. Regulated RNA stability in the Gram positives. Curr Opin Microbiol 2011, 14:148-154.
34. Seif E, Altman S. RNase P cleaves the adenine riboswitch and stabilizes pbuE mRNA in Bacillus subtilis. RNA 2008, 14:1237-1243.
35. Condon C, Putzer H. The phylogenetic distribution of bacterial ribonucleases. Nucleic Acids Res 2002, 30:5339-5346.
36. Olson PD, Kuechenmeister LJ, Anderson KL, Daily S, Beenken KE, Roux CM, Reniere ML, Lewis TL, Weiss WJ, Pulse M, et al. Small molecule inhibitors of Staphylococcus aureus RnpA alter cellular mRNA turnover, exhibit antimicrobial activity, and attenuate pathogenesis. PLoS Pathog 2011, 7:e1001287.
37. Even S, Pellegrini O, Zig L, Labas V, Vinh J, Brechemmier-Baey D, Putzer H. Ribonucleases J1 and J2: two novel endoribonucleases in B.subtilis with functional homology to E.coli RNase E. Nucleic Acids Res 2005, 33:2141-2152.
38. Chaudhuri RR, Allen AG, Owen PJ, Shalom G, Stone K, Harrison M, Burgis TA, Lockyer M, Garcia-Lara J, Foster SJ, et al. Comprehensive identification of essential Staphylococcus aureus genes using transposon-mediated differential hybridisation (TMDH). BMC Genomics 2009, 10:291.
39. Kobayashi K, Ehrlich SD, Albertini A, Amati G, Andersen KK, Arnaud M, Asai K, Ashikaga S, Aymerich S, Bessieres P, et al. Essential Bacillus subtilis genes. Proc Natl Acad Sci U S A 2003, 100:4678-4683.
40. van Dijk EL, Schilders G, Pruijn GJ. Human cell growth requires a functional cytoplasmic exosome, which is involved in various mRNA decay pathways. RNA 2007, 13:1027-1035.
41. Allmang C, Petfalski E, Podtelejnikov A, Mann M, Tollervey D, Mitchell P. The yeast exosome and human PM-Scl are related complexes of 3'->5' exonucleases. Genes Dev 1999, 13:2148-2158.
42. Raijmakers R, Egberts WV, van Venrooij WJ, Pruijn GJ. Protein-protein interactions between human exosome components support the assembly of RNase PH-type subunits into a six-membered PNPase-like ring. J Mol Biol 2002, 323:653-663.
43. Midtgaard SF, Assenholt J, Jonstrup AT, Van LB, Jensen TH, Brodersen DE. Structure of the nuclear exosome component Rrp6p reveals an interplay between the active site and the HRDC domain. Proc Natl Acad Sci U S A 2006, 103:11898-11903.
44. Staals RH, Bronkhorst AW, Schilders G, Slomovic S, Schuster G, Heck AJ, Raijmakers R, Pruijn GJ. Dis3-like 1: a novel exoribonuclease associated with the human exosome. EMBO J 2010, 29:2358-2367.
45. Tomecki R, Kristiansen MS, Lykke-Andersen S, Chlebowski A, Larsen KM, Szczesny RJ, Drazkowska K, Pastula A, Andersen JS, Stepien PP, et al. The human core exosome interacts with differentially localized processive RNases: hDIS3 and hDIS3L. EMBO J 2010, 29:2342-2357.
46. Burkard KT, Butler JS. A nuclear 3'-5' exonuclease involved in mRNA degradation interacts with Poly(A) polymerase and the hnRNA protein Npl3p. Mol Cell Biol 2000, 20:604-616.
47. Gesteland RF. Isolation and characterization of ribonuclease I mutants of Escherichia coli. J Mol Biol 1966, 16:67-84.
48. Apirion D, Watson N. Mapping and characterization of a mutation in Escherichia coli that reduces the level of ribonuclease III specific for double-stranded ribonucleic acid. J Bacteriol 1975, 124:317-324.
49. Lee K, Bernstein JA, Cohen SN. RNase G complementation of rne null mutation identifies functional interrelationships with RNase E in Escherichia coli. Mol Microbiol 2002, 43:1445-1456.
50. Horiuchi T, Maki H, Sekiguchi M. RNase H-defective mutants of Escherichia coli: a possible discriminatory role of RNase H in initiation of DNA replication. Mol Gen Genet 1984, 195:17-22.
51. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, Tomita M, Wanner BL, Mori H. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2006, 2:2006 0008.
52. Schedl P, Primakoff P. Mutants of Escherichia coli thermosensitive for the synthesis of transfer RNA. Proc Natl Acad Sci U S A 1973, 70:2091-2095.
53. Asha PK, Deutscher MP. Escherichia coli CAN lacks a tRNA-processing nuclease. J Bacteriol 1983, 156:419-420.
54. Reiner AM. Isolation and mapping of polynucleotide phosphorylase mutants of Escherichia coli. J Bacteriol 1969, 97:1431-1436.
55. Nikolaev N, Folsom V, Schlessinger D. Escherichia coli mutants deficient in exoribonucleases. Biochem Biophys Res Commun 1976, 70:920-924.
56. Blouin RT, Zaniewski R, Deutscher MP. Ribonuclease D is not essential for the normal growth of Escherichia coli or bacteriophage T4 or for the biosynthesis of a T4 suppressor tRNA. J Biol Chem 1983, 258:1423-1426.
57. Craven MG, Henner DJ, Alessi D, Schauer AT, Ost KA, Deutscher MP, Friedman DI. Identification of the rph (RNase PH) gene of Bacillus subtilis: evidence for suppression of cold-sensitive mutations in Escherichia coli. J Bacteriol 1992, 174:4727-4735.
58. Padmanabha KP, Deutscher MP. RNase T affects Escherichia coli growth and recovery from metabolic stress. J Bacteriol 1991, 173:1376-1381.
59. de Berardinis V, Vallenet D, Castelli V, Besnard M, Pinet A, Cruaud C, Samair S, Lechaplais C, Gyapay G, Richez C, et al. A complete collection of single-gene deletion mutants of Acinetobacter baylyi ADP1. Mol Syst Biol 2008, 4:174.
60. Kaito C, Kurokawa K, Matsumoto Y, Terao Y, Kawabata S, Hamada S, Sekimizu K. Silkworm pathogenic bacteria infection model for identification of novel virulence genes. Mol Microbiol 2005, 56:934-944.
61. Gao P, Pinkston KL, Nallapareddy SR, van Hoof A, Murray BE, Harvey BR. Enterococcus faecalis rnjB is required for pilin gene expression and biofilm formation. J Bacteriol 2010, 192:5489-5498.
62. Deutscher MP. Degradation of RNA in bacteria: comparison of mRNA and stable RNA. Nucleic Acids Res 2006, 34:659-666.
63. Li H. Complexes of tRNA and maturation enzymes: shaping up for translation. Curr Opin Struct Biol 2007, 17:293-301.
64. Mathy N, Benard L, Pellegrini O, Daou R, Wen T, Condon C. 5'-to-3' exoribonuclease activity in bacteria: role of RNase J1 in rRNA maturation and 5' stability of mRNA. Cell 2007, 129:681-692.
65. Fang M, Zeisberg WM, Condon C, Ogryzko V, Danchin A, Mechold U. Degradation of nanoRNA is performed by multiple redundant RNases in Bacillus subtilis. Nucleic Acids Res 2009, 37:5114-5125.
66. Jarrous N, Reiner R. Human RNase P: a tRNA-processing enzyme and transcription factor. Nucleic Acids Res 2007, 35:3519-3524.
67. Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 2007, 6:29-40.
68. Clatworthy AE, Pierson E, Hung DT. Targeting virulence: a new paradigm for antimicrobial therapy. Nat Chem Biol 2007, 3:541-548.
69. Tobe T, Sasakawa C, Okada N, Honma Y, Yoshikawa M. vacB, a novel chromosomal gene required for expression of virulence genes on the large plasmid of Shigella flexneri. J Bacteriol 1992, 174:6359-6367.
70. Cheng ZF, Zuo Y, Li Z, Rudd KE, Deutscher MP. The vacB gene required for virulence in Shigella flexneri and Escherichia coli encodes the exoribonuclease RNase R. J Biol Chem 1998, 273:14077-14080.
71. Erova TE, Kosykh VG, Fadl AA, Sha J, Horneman AJ, Chopra AK. Cold shock exoribonuclease R (VacB) is involved in Aeromonas hydrophila pathogenesis. J Bacteriol 2008, 190:3467-3474.
72. Miyoshi A, Rosinha GM, Camargo IL, Trant CM, Cardoso FC, Azevedo V, Oliveira SC. The role of the vacB gene in the pathogenesis of Brucella abortus. Microbes Infect 2007, 9:375-381.
73. Andrade JM, Arraiano CM. PNPase is a key player in the regulation of small RNAs that control the expression of outer membrane proteins. RNA 2008, 14:543-551.
74. Rosenzweig JA, Weltman G, Plano GV, Schesser K. Modulation of Yersinia type three secretion system by the S1 domain of polynucleotide phosphorylase. J Biol Chem 2005, 280:156-163.
75. Rosenzweig JA, Chromy B, Echeverry A, Yang J, Adkins B, Plano GV, McCutchen-Maloney S, Schesser K. Polynucleotide phosphorylase independently controls virulence factor expression levels and export in Yersinia spp. FEMS Microbiol Lett 2007, 270:255-264.
76. Clements MO, Eriksson S, Thompson A, Lucchini S, Hinton JC, Normark S, Rhen M. Polynucleotide phosphorylase is a global regulator of virulence and persistency in Salmonella enterica. Proc Natl Acad Sci U S A 2002, 99:8784-8789.
77. Barnett TC, Bugrysheva JV, Scott JR. Role of mRNA stability in growth phase regulation of gene expression in the group A streptococcus. J Bacteriol 2007, 189:1866-1873.
78. Wagner EG, Altuvia S, Romby P. Antisense RNAs in bacteria and their genetic elements. Adv Genet 2002, 46:361-398.
79. Huntzinger E, Boisset S, Saveanu C, Benito Y, Geissmann T, Namane A, Lina G, Etienne J, Ehresmann B, Ehresmann C, et al. Staphylococcus aureus RNAIII and the endoribonuclease III coordinately regulate spa gene expression. EMBO J 2005, 24:824-835.
80. Boisset S, Geissmann T, Huntzinger E, Fechter P, Bendridi N, Possedko M, Chevalier C, Helfer AC, Benito Y, Jacquier A, et al. Staphylococcus aureus RNAIII coordinately represses the synthesis of virulence factors and the transcription regulator Rot by an antisense mechanism. Genes Dev 2007, 21:1353-1366.
81. Liu Y, Dong J, Wu N, Gao Y, Zhang X, Mu C, Shao N, Fan M, Yang G. The production of extracellular proteins is regulated by ribonuclease III via two different pathways in Staphylococcus aureus. PLoS One 2011, 6:e20554.
82. Nagata M, Kaito C, Sekimizu K. Phosphodiesterase activity of CvfA is required for virulence in Staphylococcus aureus. J Biol Chem 2008, 283:2176-2184.
83. Kang SO, Caparon MG, Cho KH. Virulence gene regulation by CvfA, a putative RNase: the CvfA-enolase complex in Streptococcus pyogenes links nutritional stress, growth-phase control, and virulence gene expression. Infect Immun 2010, 78:2754-2767.
84. Tramontano E, Di Santo R. HIV-1 RT-associated RNase H function inhibitors: recent advances in drug development. Curr Med Chem 2010, 17:2837-2853.
85. Yanagita H, Urano E, Matsumoto K, Ichikawa R, Takaesu Y, Ogata M, Murakami T, Wu H, Chiba J, Komano J, Hoshino T. Structural and biochemical study on the inhibitory activity of derivatives of 5-nitro-furan-2-carboxylic acid for RNase H function of HIV-1 reverse transcriptase. Bioorg Med Chem 2011, 19:816-825.
86. Kim WC, Lee CH. The role of mammalian ribonucleases (RNases) in cancer. Biochim Biophys Acta 2009, 1796:99-113.
87. Curran TP, Shapiro R, Riordan JF. Alteration of the enzymatic specificity of human angiogenin by site-directed mutagenesis. Biochemistry 1993, 32: 2307-2313.
88. Olson KA, Fett JW, French TC, Key ME, Vallee BL. Angiogenin antagonists prevent tumor growth in vivo. Proc Natl Acad Sci U S A 1995, 92:442-446.
89. Olson KA, Byers HR, Key ME, Fett JW. Inhibition of prostate carcinoma establishment and metastatic growth in mice by an antiangiogenin monoclonal antibody. Int J Cancer 2002, 98:923-929.
90. Olson KA, Byers HR, Key ME, Fett JW. Prevention of human prostate tumor metastasis in athymic mice by antisense targeting of human angiogenin. Clin Cancer Res 2001, 7:3598-3605.
91. Gho YS, Yoon WH, Chae CB. Antiplasmin activity of a peptide that binds to the receptor-binding site of angiogenin. J Biol Chem 2002, 277:9690-9694.
92. Kao RY, Jenkins JL, Olson KA, Key ME, Fett JW, Shapiro R. A small-molecule inhibitor of the ribonucleolytic activity of human angiogenin that possesses antitumor activity. Proc Natl Acad Sci U S A 2002, 99:10066-10071.